|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1984-3-14
|
|
pubmed:abstractText |
The prostaglandin E1 increases the plasma concentration of acute-phase proteins in man and decreases the concentration of certain carrier proteins. This response is greatly diminished in patients with systemic sclerosis, a chronic inflammatory disease leading to fibrosis. These findings pose new questions about the mediation of the acute-phase response and its role in controlling the inflammatory process.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alprostadil,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Ceruloplasmin,
http://linkedlifedata.com/resource/pubmed/chemical/Chymotrypsin,
http://linkedlifedata.com/resource/pubmed/chemical/Haptoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Orosomucoid,
http://linkedlifedata.com/resource/pubmed/chemical/Prealbumin,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins E,
http://linkedlifedata.com/resource/pubmed/chemical/Retinol-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Retinol-Binding Proteins, Plasma,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Amyloid A Protein,
http://linkedlifedata.com/resource/pubmed/chemical/alpha 1-Antichymotrypsin,
http://linkedlifedata.com/resource/pubmed/chemical/alpha 1-Antitrypsin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0143-5221
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-71
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6607151-Alprostadil,
pubmed-meshheading:6607151-Blood Proteins,
pubmed-meshheading:6607151-C-Reactive Protein,
pubmed-meshheading:6607151-Ceruloplasmin,
pubmed-meshheading:6607151-Chymotrypsin,
pubmed-meshheading:6607151-Haptoglobins,
pubmed-meshheading:6607151-Humans,
pubmed-meshheading:6607151-Orosomucoid,
pubmed-meshheading:6607151-Prealbumin,
pubmed-meshheading:6607151-Prostaglandins E,
pubmed-meshheading:6607151-Retinol-Binding Proteins,
pubmed-meshheading:6607151-Retinol-Binding Proteins, Plasma,
pubmed-meshheading:6607151-Scleroderma, Systemic,
pubmed-meshheading:6607151-Serum Amyloid A Protein,
pubmed-meshheading:6607151-alpha 1-Antichymotrypsin,
pubmed-meshheading:6607151-alpha 1-Antitrypsin
|
|
pubmed:year |
1984
|
|
pubmed:articleTitle |
Prostaglandins cause an increase in serum acute-phase proteins in man, which is diminished in systemic sclerosis.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
